EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy

Peng Bao, Hui-Yun Gu, Jing-Jie Ye, Jin-Lian He, Zhenlin Zhong, Ai-Xi Yu, Xian-Zheng Zhang

Advanced Science · 2024-02 · 11 (6)

DOI: 10.1002/advs.202306336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 10.12.2023. Verfasst von Peng Bao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China. Hauptthemen laut MEDLINE: Glioblastoma, Exosomes. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A critical challenge of existing cancer vaccines is to orchestrate the demands of antigen‐enriched furnishment and optimal antigen‐presentation functionality within antigen‐presenting cells (APCs). Here, a complementary immunotherapeutic strategy is developed using dendritic cell (DC)‐tumor hybrid cell‐derived chimeric exosomes loaded with stimulator of interferon genes (STING) agonists (DT‐Exo‐STING) for maximized tumor‐specific T‐cell immunity. These chimeric carriers are furnished with broad‐spectrum antigen complexes to elicit a robust T‐cell‐mediated inflammatory program through direct self‐presentation and indirect DC‐to‐T immunostimulatory pathway. This chimeric exosome‐assisted delivery strategy possesses the merits versus off‐the‐shelf cyclic dinucleotide (CDN) delivery techniques in both the brilliant tissue‐homing capacity, even across the intractable blood–brain barrier (BBB), and the desired cytosolic entry for enhanced STING‐activating signaling. The improved antigen‐presentation performance with this nanovaccine‐driven STING activation further enhances tumor‐specific T‐cell immunoresponse. Thus, DT‐Exo‐STING reverses immunosuppressive glioblastoma microenvironments to pro‐inflammatory, tumoricidal states, leading to an almost obliteration of intracranial primary lesions. Significantly, an upscaling option that harnesses autologous tumor tissues for personalized DT‐Exo‐STING vaccines increases sensitivity to immune checkpoint blockade (ICB) therapy and exerts systemic immune memory against post‐operative glioma recrudesce. These findings represent an emerging method for glioblastoma immunotherapy, warranting further exploratory development in the clinical realm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaExosomesHumansT-LymphocytesAntigen PresentationImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

STING activationT cell responseschimeric exosomesglioblastomapersonalized immunotherapy

Autor:innen und Institutionen

  • Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China.
  • Department of Orthopedic Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, P. R. China.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Bao, P., Gu, H. Y., Ye, J. J., He, J. L., Zhong, Z., Yu, A. X., & Zhang, X. Z. (2024). Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy. Advanced Science, 11(6). https://doi.org/10.1002/advs.202306336

Vancouver

Bao P, Gu HY, Ye JJ, He JL, Zhong Z, Yu AX, et al. Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy. Advanced Science. 2024;11(6). doi:10.1002/advs.202306336

BibTeX
@article{Bao2024,
  author = {Bao, Peng and Gu, Hui-Yun and Ye, Jing-Jie and He, Jin-Lian and Zhong, Zhenlin and Yu, Ai-Xi and Zhang, Xian-Zheng},
  title = {Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {6},
  doi = {10.1002/advs.202306336}
}
Kostenlos starten →